119th Congress
H.R. 1143
Medicare IVIG Access Enhancement Act of 2025
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Adrian Smith(R-NE)
- Introduced
- Feb 7, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce; House Committee on Ways and Means
- Official text
- Introduced in House · Congress.gov page
Cosponsors (2)
Original cosponsors (1)
- John Garamendi (D-CA)
Added later (1)
- Eugene Simon Vindman (D-VA) · Nov 4, 2025
Summary
Summary by the Congressional Research Service· describes the “Introduced in House” version
Medicare IVIG Access Enhancement Act of 2025
This bill provides for Medicare coverage of in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy (CIDP) or multifocal motor neuropathy. (CIDP is an autoimmune condition that causes symptoms such as muscle weakness and numbness; multifocal motor neuropathy is a variant of CIDP that only causes asymmetric muscle weakness.)
Roll-call votes
No recorded votes on this bill.
Actions
- Feb 7, 2025 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. - Feb 7, 2025
Introduced in House